Aurelian
L, Kokuba H, Smith CC. Vaccine potential of a herpes simplex virus
type 2 mutant deleted in the PK domain of the large subunit of ribonucleotide
reductase (ICP10). Vaccine. 1999 Apr 9;17(15-16):1951-63.
Wachsman
M, Kulka M, Smith CC, Aurelian L. A growth and latency compromised
herpes simplex virus type 2 mutant (ICP10DeltaPK) has prophylactic
and therapeutic protective activity in guinea pigs. Vaccine. 2001
Feb 28;19(15-16):1879-90.
Gyotoku
T, Ono F, Aurelian L. Development of HSV-specific CD4+ Th1 responses
and CD8+ cytotoxic T lymphocytes with antiviral activity by vaccination
with the HSV-2 mutant ICP10DeltaPK. Vaccine. 2002 Jun 21;20(21-22):2796-807
|